Marti A, Martinez-Gonzalez MA, Martinez JA. Interaction between genes and lifestyle factors on obesity. Proc Nutr Soc 2008; 67: 1–8

Metwally M, Li TC, Ledger WL. The impact of obesity on female reproductive function. Obesity Rev 2007; 8: 515–23.

Frisch RE, McArthur JW. Menstrual cycle: fatness as a determinant of minimum weight for height necessary for their maintenance or onset. Science 1974; 185: 949–951.

Chen D, Misra A, Garg A. Lipodystrophy in human immunodeficiency virus-infected patients J Clin Endocrinol Metab. 2002 Nov;87(11):4845-56.

Holstein A, Plaschke A, Egberts EH. Lipodystrophy and metabolic disorders as complication of antiretroviral therapy of HIV infection Exp Clin Endocrinol Diabetes. 2001;109(8):389-92.

Grinspoon SK. Metabolic syndrome and cardiovascular disease in patients with human immunodeficiency virus Am J Med. 2005 Apr;118 Suppl 2:23S-28S.

Aldersberg, D. & Mayer, M. Results of prolonged medical treatment of obesity. Journal of Clinical Endocrinology, 9, 1949, 275–284.

Rotter, J.B. Generalized expectancies of internal versus external control of reinforcements. Psychological Monographs, 80, 1966.

Fitzgibbon, Marian L.; Stolley, Melinda R. & Kirschenbaum, Daniel S. Health Psychology, Vol 12(5), September 1993, 342–345.

Chang CC, Cheng CJ, Sung CC, Chiueh TS, Lee CH, Chau T & Lin SH. A 10-year analysis of thyrotoxic periodic paralysis in 135 patients: focus on symptomatology and precipitants. Eur J Endocrinology, 2013; 169: 529–536.

Kung AW. Clinical review: thyrotoxic periodic paralysis: a diagnostic challenge. Journal of Clinical Endocrinology and Metabolism. 2006; 91:2490–2495.

Falhammar H, Thore´n M, Calissendorff J. Thyrotoxic periodic paralysis: clinical and molecular aspects. Endocrine, 2013; 43: 274–284.

POLL/Neuropathy & Thyroid – Please Join – Thyroid Disorders- MedHelp

Bahn SR, Burch BH, Cooper SD, Garber RJ, Greenlee MC, Klein J, Laurberg P, Mc Dougall JR, Montori M V, Rivkees AS, Ross SD, Sosa AJ, Stan NM: Hyperthyroidism and Other Causes of Thyrotoxicosis: Menagement guidelines of the American Thyroid Association and

Beghi E, Delodovici M, Bogliun G, Crespi V, Paleari F, Gamba P, Capra M, Zarelli M. Hypothyroidism and polyneuropathy. J Neurol Neurosurg Psychiatry 1989 ; 52: 1420-1423

Colman RW, Clowes AW, George JN, Goldhaber SZ, Marder VJ. Overview of hemostasis. In: Colman RW, Marder VJ, Clowes AW, George JN, Goldhaber SZ. Haemostasis and Thrombosis: basic principles and clinical practice. 5th ed. Philadelphia: Lippencott Wiliams &

Degen JL. Genetic interactions between the coagulation and fibrinolytic systems. Thromb Haemost 2001; 86(1):130-7

Akhter MS, Biswas A, Ranjan R, et al. Plasminogen activator inhibitor-1 (PAI-1) gene 4G/5G promoter polymorphism is seen in higher frequency in the Indian patients with deep vein thrombosis. Clin Appl Thromb Hemost. 2010 Apr; 16(2):184-8.

Paunkovic N, Paunkovic J. 1998. Associated Graves' disease and Plummer's disease: Variant of Marine-Lenhart syndrome or distinct clinical entity? 25th Annual Meeting of the European Thyroid Association – Clinical Thyroid Day. Athens 1988 (abstract book).

N.D. Paunkovic, J.A. Paunkovic: Autonomous functioning nodule and Graves' disease. 12th International Thyroid Congress, Kyoto 2000. Page 148 (abst P-171).

Paunkovic N, Paunkovic J. 2003: Associated Graves' and Plummer's disease. Hellenic Journal of Nuclear Medicine, 6(1): 44-47.

Kronenberg HK, Melmed S, Polonsky KS, Larsen PR, eds. 2008. Williams textbook of endocrinology. 11th ed. Philadelphia, PA: Saunders; 505–537.

Funder JW, Carey RM, Fardella C et al. Case Detection, Diagnosis, and Treatment of Patients with Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline. J. Clin. Endocrinol. Metab. 2008; 93:3266–3281.

Hannemann A, Bidlingmaier M, Friedrich N. Screening for primary aldosteronism in hypertensive subjects: results from two German epidemiological studies. Eur J Endocrinol. 2012; 167:7–15.